← SynDRA
RG2833
SynDRA canonical compound SYN1970641 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | HDAC1 | HDAC3 |
|---|
| Mechanism of action | HDAC inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- histone deacetylase inhibitor
Cross-references
Synonyms
- RG-2833
- N-(6-((2-Aminophenyl)amino)-6-oxohexyl)-4-methylbenzamide
- RGFP-109
- RGFP109
- RG2833 (RGFP109)
- N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide
- 17V14R89EU
- N-[6-(2-aminoanilino)-6-oxohexyl]-4-methylbenzamide
- N-[6-(2-aminophenylamino)-6-oxohexyl]-4-methylbenzamide
- UNII-17V14R89EU
- SCHEMBL529065
- GTPL7501
- CHEMBL3970532
- DTXSID20153300
- EX-A767
- RG 2833 [WHO-DD]
- BDBM207629
- HMS3653O08
- HMS3747M17
- HMS3886B13
- MFCD25976845
- s7292
- ZINC96170452
- AKOS030525997
- CCG-267917
- CS-1526
- NCGC00381565-04
- AC-33034
- AS-55992
- HY-16425
- US9265734, R01
- FT-0700118
- SW219374-1
- A13139
- A891588
- J-690067
- Q27088540
- N-(2-aminophenyl)-6-[(4-methylphenyl)formamido]hexanamide
- 3-(1H-Indol-5-yl)-5-{4-[(4-methyl-1-piperazinyl)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridine
Look up RG2833 in the interactive SynDRA portal →